A novel, bacteria-repelling coating material that could increase the success of medical implants has been created by researchers.
The material helps healthy cells 'win the race' to the medical implant, beating off competition from bacterial cells and thus reducing the likelihood of the implant being rejected by the body.
The first results of the material's performance have been published today, 30 January, in IOP Publishing's journal Biomedical Materials.
The failure rate of certain medical implants still remains high--around 40% for hip implants--due to the formation of biofilms when the implant is first inserted into the body.
This thin film is composed of a group of microorganisms stuck together and can be initiated by bacteria sticking to the implant. This prevents healthy cells from attaching and results in the body eventually rejecting the implant, potentially leading to serious complications for patients.
In their study, researchers from A*STAR (Agency for Science, Technology and Research) in Singapore, Nanyang Technological University and University of Hong Kong produced a material that not only repelled bacteria but also attracted healthy cells.
The base of the material was made from polyelectrolyte multilayers onto which a number of specific bonding molecules, called ligands, were attached.
After testing various concentrations of different ligands, the researchers found that RGD peptide was particularly effective at inhibiting the attachment of bacterial cells and attracting healthy cells, compared with collagen, when attached to dextran sulfate and chitosan multilayers.
This combination was tested on cultures of healthy fibroblast cells and cultures of bacterial cells, in which two specific strains were used--E. coli and S. aureus.
The lead author of the research, Professor Vincent Chan from Nanyang Technological University, said: "The method we developed helped the host cells win the so called 'race-for-surface' battle, forming a confluent layer on the implant surface which protects it from possible bacterial adhesion and colonization.
"Medical implants currently have antibacterial silver coatings incorporated into them; however, the total amount of silver used must be very carefully controlled because high concentrations could kill mammalian cells and become toxic to the human body.
"The bio-selective coatings we've created do not have this problem as the materials used are non-toxic and the preparation process uses water as a solvent.
"At the moment this is just a 'proof-of-concept' study, so there is still a long way to go before the coating can be used on implants in clinical setting. In future studies we hope to firstly improve the long-term stability of the coating."
From Friday 30 January, this paper can be downloaded from http://iopscience.
Notes to Editors
1. For further information, a full draft of the journal paper or contact with one of the researchers, contact IOP Press Officer, Michael Bishop: Tel: 0117 930 1032 E-mail: email@example.com . For more information on how to use the embargoed material above, please refer to our embargo policy.
IOP Publishing Journalist Area
2. The IOP Publishing Journalist Area gives journalists access to embargoed press releases, advanced copies of papers, supplementary images and videos. In addition to this, a weekly news digest is uploaded into the Journalist Area every Friday, highlighting a selection of newsworthy papers set to be published in the following week. Login details also give free access to IOPscience, IOP Publishing's journal platform. To apply for a free subscription to this service, please email Michael Bishop, IOP Press Officer, firstname.lastname@example.org, with your name, organisation, address and a preferred username.
Engineering bio-adhesive functions in antimicrobial polymer multilayer
3. The published version of the paper 'Engineering bio-adhesive functions in antimicrobial polymer multilayer' (He et al 2015 BMM 10 015015) will be freely available online from Thursday 29 January. It will be available at http://iopscience.
4. Biomedical Materials publishes original research findings that contribute to our knowledge about the composition, properties and performance of materials for tissue engineering and regenerative medicine.
5. IOP Publishing provides publications through which leading-edge scientific research is distributed worldwide.
Beyond our traditional journals programme, we make high-value scientific information easily accessible through an ever-evolving portfolio of books, community websites, magazines, conference proceedings and a multitude of electronic services.
IOP Publishing is central to the Institute of Physics, a not-for-profit society. Any financial surplus earned by IOP Publishing goes to support science through the activities of the Institute.
Go to ioppublishing.org.
Access to Research
6. Access to Research is an initiative through which the UK public can gain free, walk-in access to a wide range of academic articles and research at their local library. This article is freely available through this initiative. For more information, go to http://www.
The Institute of Physics
6. The Institute of Physics is a leading scientific society. We are a charitable organisation with a worldwide membership of more than 50,000, working together to advance physics education, research and application.
We engage with policymakers and the general public to develop awareness and understanding of the value of physics and, through IOP Publishing, we are world leaders in professional scientific communications.
In September 2013, we launched our first fundraising campaign. Our campaign, Opportunity Physics, offers you the chance to support the work that we do.